News for hackers. Stuff that matters.
Re:Economic Analysis of Medicare for All by monocasa on Wednesday December 05, 2018 @07:51PM (#18614363)
I know that's what's pushed, but how much of that is true? Federal grants pay for a lot of initial frubt work, and drug companies spend around twice as much on marketing as they do on R&D. And that's with all sorts of tax benefits behooving them to call as much as possible of their budget R&D.
Re:Economic Analysis of Medicare for All by ekianjo on Wednesday December 05, 2018 @09:23PM (#18614850)
Marketing is needed everywhere, pharma included. You dont spread awareness of a new drug just by filing an application to the FDA. And marketing expenses are high because potential returns are high and make or break a drug. Note that you dont have really new drugs every year so you need marketing anyway to convince prescribers why your version of the drug in the same class as your competitor is slightly better. In reality most drugs of the same class are pretty similar in efficacy and side effects, but thats a tangential topic.